FIGURE 2.
Individual observed pharmacokinetic profiles for: (a) apixaban (normalized to 5 mg b.i.d.); (b) rivaroxaban (normalized to 20 mg q.d.); (c) rivaroxaban 15 mg b.i.d. Black dots = mean ± SD.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.